Free Trial

Brainstorm Cell Therapeutics (BCLI) SEC Filings & 10K Form

Brainstorm Cell Therapeutics logo
$1.27 +0.01 (+0.79%)
(As of 09:30 AM ET)

Recent Brainstorm Cell Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
2:24 PM
ARMISTICE CAPITAL, LLC (Filed by)
Brainstorm Cell Therapeutics (Subject)
Form SC 13G
11/13/2024
6:55 AM
Brainstorm Cell Therapeutics (Subject)
Ruck Matthew J (Filed by)
Form SC 13G
10/30/2024
7:41 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
7:00 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
7:00 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2024
11:15 PM
Brainstorm Cell Therapeutics (Filer)
Form EFFECT
09/26/2024
3:30 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
3:30 PM
Brainstorm Cell Therapeutics (Filer)
Form S-3/A
09/17/2024
2:32 PM
Brainstorm Cell Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/16/2024
3:36 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2024
11:15 PM
Brainstorm Cell Therapeutics (Filer)
Form EFFECT
08/28/2024
4:01 PM
Brainstorm Cell Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/16/2024
6:00 AM
Brainstorm Cell Therapeutics (Filer)
Form DEF 14A
08/16/2024
6:03 AM
Brainstorm Cell Therapeutics (Filer)
Form ARS
08/14/2024
7:01 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
6:15 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
3:08 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:09 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:05 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:06 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:06 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:07 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:07 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/24/2024
3:05 PM
Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:05 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
9:49 AM
Brainstorm Cell Therapeutics (Filer)
Form 424B5
06/28/2024
6:30 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
8:00 AM
Brainstorm Cell Therapeutics (Filer)
Form 424B5
06/26/2024
3:01 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
8:03 PM
Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/25/2024
8:04 PM
Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:24 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
5:05 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
8:00 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:00 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
6:53 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
6:41 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
8:14 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
3:06 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
3:01 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:06 PM
Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

04/19/2024
5:05 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
8:31 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
5:10 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
5:05 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
3:15 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
8:16 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024
7:15 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:54 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
7:55 PM
Brainstorm Cell Therapeutics (Issuer)
Patlis Alla (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
7:56 PM
Brainstorm Cell Therapeutics (Issuer)
Yablonka Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
7:57 PM
Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
9:06 AM
Brainstorm Cell Therapeutics (Subject)
Ness Kevin Dean (Filed by)
Form SC 13G/A
12/20/2023
4:04 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
5:03 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BCLI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners